Pesquisas alternativas:
naive level » five level (Expandir a Pesquisa), live level (Expandir a Pesquisa), negative level (Expandir a Pesquisa)
doses laser » does laser (Expandir a Pesquisa), dose laser (Expandir a Pesquisa), doses based (Expandir a Pesquisa)
mode novel » model novel (Expandir a Pesquisa), modes novel (Expandir a Pesquisa), modern novel (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
laser ther » laser theory (Expandir a Pesquisa), laser thermo (Expandir a Pesquisa), laser three (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 115 para a pesquisa '(( drug mode novel ther ) OR ((( drug doses laser ther ) OR ( drug naive level ther ))))', tempo de pesquisa: 1.74seg Refinar resultados
T-bet expression in rheumatoid arthritis patients with early, disease-modifying anti-rheumatic drug naïve disease is low and correlates with low levels of IL-7 and T-cell dysfunctions
Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis

Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania
Effect of Metformin Glycinate on Glycated Hemoglobin A1c Concentration and Insulin Sensitivity in Drug-Naive Adult Patients with Type 2 Diabetes Mellitus

THER-29. NOVEL DUAL EGFR/PI3-KINASE INHIBITORS SHOW ENHANCED POTENCY, STRONGER PATHWAY SUPPRESSION AND TARGETING OF METABOLIC PROPERTIES IN PEDIATRIC AND ADULT HIGH GRADE GLIOMA MODELS THAN SINGLE KINASE INHIBITORS
Efavirenz Therapeutic Range in HIV-1 Treatment Naïve Participants

Antidiabetic phytoconstituents and their mode of action on metabolic pathways
Baracle(®) vs Baraclude(®) for 48 weeks in patients with treatment-naïve chronic hepatitis B: a comparison of efficacy and safety

Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients

Efficacy and Safety of S-Amlodipine 2.5 and 5 mg/d in Hypertensive Patients Who Were Treatment-Naive or Previously Received Antihypertensive Monotherapy
Redefining Affective Disorders: Relevance for Drug Development

The Development of Novel Therapies for Rheumatoid Arthritis
Functional miRNAs in breast cancer drug resistance

Orphan neuropeptides and receptors: Novel therapeutic targets
Hedgehog pathway as a drug target: Smoothened inhibitors in development

Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study
Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion

Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents
PHYLOGENETIC EVIDENCE OF HIV-1 SEQUENCE EVOLUTION IN SUBJECTS WITH PERSISTENT LOW-LEVEL VIREMIA

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa